Educational information only. Not medical advice. Talk to a qualified healthcare professional before using any compound. Disclaimer

LimitlessLab
Search the library Wishlist Cart, items: 0
Cerebrolysin

Cognitive & Brain

Cerebrolysin

Also known as FPF-1070

Moderate human evidencePrescription in some countries

Price range: €110 through €205

Discussed for: Recovery after stroke, brain injury, dementia.

Sequence: not listed. Modified or non-standard residues are left out on purpose.

Effect strengthHow hard it acts on the body5/10
Proof levelHow well that is shown in humans6/10
Risk levelHow much can go wrong3/10

Editorial 1 to 10 estimates from published research, not measured values. How to read these

Save to wishlist
Save to wishlist

01 / Identity

What it is

Cerebrolysin is a peptide mixture from pig brain. Main reported uses: recovery after stroke, brain injury, dementia. Current status: prescription in ~50 countries (not US).

Molecule type
Peptide mixture from pig brain
How it is taken
Injection (IV/IM)
Other names
FPF-1070

Route only. This library does not publish doses or protocols.

02 / Mechanism

How it is thought to work

Mix of neuropeptides that supports neuron repair and survival

03 / Potential benefits

What people use it for

Recovery after stroke, brain injury, dementia

Moderate human evidence

Some human trials exist, but they are smaller, shorter or mixed.

Listed uses are what people use it for, not proven outcomes.

04 / Known risks

Side effects and risks

Dizziness, headache, allergic reactions

Risk level 3 of 10

Lower risk score: reported side effects are mostly mild. Low risk is not no risk, especially for unregulated products.

Unknown long-term effects count as a risk, not as a clean record.

05 / Regulatory

Regulatory status

Status
Prescription in some countries
Details
Prescription in ~50 countries (not US)
Sport (WADA)
Not listed

Status reflects information up to mid-2026 and changes over time. Check current sources.

06 / Evidence quality

How good is the evidence?

Moderate: human trials, mixed results

How we grade evidence

07 / Notes and sources

Notes and sources

  • Anyone using compounds like this regularly should have medical supervision and bloodwork (for example IGF-1, glucose and HbA1c, hormones, lipids).
  • Source: Peptide Reference Table, an editorial review of published research up to mid-2026. Scores are 1 to 10 editorial estimates, not measured values. Regulatory and WADA status change over time.

Educational information only. Not medical advice. Talk to a qualified healthcare professional before using any compound.

Related compounds